Marcan Pharmaceuticals becomes shareholder of Mantra Pharma
Marcan Pharmaceuticals, an Ontario based pharmaceuticals company, recently became a shareholder of Mantra Pharma. This strategic move builds on their collaboration since 2014, aiming to strengthen their market position. Marcan’s investment is set to bolster Mantra’s competitiveness and accelerate business objectives while preserving brand and expertise.
Mantra’s continued focus on Quebec’s development, will expand Marcan’s Canadian portfolio. The partnership not only introduces new products but also provides direct access to molecule manufacturing, securing supplies for both companies.
Jean-François Letarte, President of Mantra Pharma, emphasizes the uniqueness of the Quebec market and the goal to enhance growth and care provision. Sudher Paladugu, President & COO of Marcan Pharmaceuticals, highlights the alignment between the organizations, aiming to support Mantra’s ascent as a leading pharmaceutical company in Quebec.
LaBarge Weinstein acted as counsel to Marcan Pharmaceuticals with a team that included Debbie Weinstein, Jordan Potechin, Alicia Grant and Kirsten Saikaly.
Read more about this: Marcan Pharmaceuticals becomes shareholder of Mantra Pharma